Although DCAF15 is a strong determinant for indisulam sensitivity as shown by us and others14,15, a recent study suggested that DCAF15 mRNA levels in primary samples of tumour cells of AML patients did not correlate to RBM39 degradation36. This evidence concerns the gene RBM39 and neoplasm.